Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 37.00 | |
5 mg | In stock | $ 59.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 179.00 | |
50 mg | In stock | $ 318.00 | |
100 mg | In stock | $ 473.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes. |
Synonyms | Gd-EOB-DTPA Disodium, ZK 139834 |
Molecular Weight | 725.71 |
Formula | C23H28GdN3Na2O11 |
CAS No. | 135326-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.03 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gadoxetate Disodium 135326-22-6 Others Inhibitor Gd-EOB-DTPA Disodium ZK-139834 Gadoxetate ZK139834 Gd-EOB-DTPA ZK 139834 inhibit inhibitor